Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEquipmake Regulatory News (EQIP.PL)

Share Price Information for Equipmake (EQIP.PL)

Share Price is delayed by 15 minutes
Get Live Data
1.25    0.00 (0.00%)
Bid:
1.00
Ask:
1.50
Spread: 0.50 (50.00%)
Market Cap: £14.00m
EQIP.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday Equipmake Share Chart

GM Statement

12 May 2025 14:32

RNS Number : 3129I
Equipmake Holdings PLC
12 May 2025
 

12 May 2025

Equipmake Holdings PLC

("Equipmake" or the "Company")

 

Result of General Meeting ("GM")

 

Equipmake, a market leader in engineering-driven differentiated electrification technologies, products and solutions across the automotive, truck, bus and speciality vehicle industries, announces that at its GM held earlier today all the resolutions set out in the Notice of GM were passed. All resolutions were voted on by way of a poll. The results of the poll for each resolution were as follows:

 

 

Resolutions

Votes For

% For

Votes Against

% Against

% If ISC* votes

Votes withheld

1. To authorise the Directors to issue shares upon conversion of the CLNs by Caterpillar.

839,412,049

96.55%

30,009,721

3.45%

N/A

125,036,999

2. To authorise the Directors to issue shares on CLN conversion without statutory pre-emption rights.

839,412,049

96.55%

 

30,009,721

3.45%

 

N/A

125,036,999

 

Notes:

 

1. All resolutions were passed.

2. Votes "For" and "Against" any resolution are expressed as a percentage of votes validly cast for that resolution.

3. A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against" any resolution.

4. The number of shares in issue on 9 May 2025 was 1,120,074,565 ordinary shares, carrying one vote each, and at that time, the Company did not hold any shares in treasury.

5. The full text of the resolutions passed at the GM can be found in the Notice of General Meeting which is available on the Company's website at www.equipmake.com.

 

 

 

**ENDS**

For further information, please contact: 

Equipmake 

Ian Foley, CEO

Ian Selby, CFO 

 

Via St Brides Partners

VSA Capital (Financial Adviser, Aquis Corporate Adviser and Broker) 

Simon Barton / Brian Wong

Tel: +44 (0) 20 3005 5000

 

 

 

 

St Brides Partners (Financial PR Adviser)

Susie Geliher / Paul Dulieu / Will Turner 

Tel: +44 (0) 20 7236 1177  equipmake@stbridespartners.co.uk 

 

About Equipmake

Equipmake is a UK-based industrial technology company specialising in the engineering, development and production of electrification products to meet the needs of the automotive and other sectors in support of the transition from fossil-fuelled to zero-emission drivetrains. 

 

Equipmake is a leader in high performance technologically advanced electric motors, inverters and complete zero-emission electric drivetrains and power electronic systems. Equipmake has developed a vertically integrated offering providing fully bespoke solutions to its customers. The Company is focussed on accelerating traction with OEM and Tier 1 suppliers in relation to higher margin component and drivetrain supply under long-term growth contracts and securing high margin licencing transactions.

 

Key differentiators of the Company offerings are its advanced technology and performance, reliability and adherence to ASIL-D1 functional safety. Equipmake's advanced motor and inverter technology, featuring ASIL-D compliance, are designed to customers' highest Functional Safety standards. With decades of experience in electric drivetrain integration and a dedicated prototype vehicle testing facility, Equipmake can significantly accelerate product development for customers.

 

1 Automotive Safety Integrity Level ("ASIL") is a risk classification scheme defined by the ISO 26262 - Functional Safety for Road Vehicles standard and is a critical requirement for road vehicles. Of the four ASILs identified by the standard, ASIL-D dictates the highest integrity requirements on the product, which require exceptional rigour in their development.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXATMJTMTJBBMA
12
Date   Source Headline
30th May 202410:00 amRNSAppointment of VP of Sales & Business Development
22nd Apr 20247:00 amRNSBoard Changes & Appointment of new CFO
8th Apr 20247:00 amRNSAppointment of Business Development Director
5th Apr 20247:00 amRNSFirst York Project Update
14th Feb 20245:51 pmRNSResult of Retail Offer
18th Jan 20247:00 amRNSInterim Results
16th Jan 20247:00 amRNSAppointment of new Chief Operating Officer
15th Jan 20247:00 amRNSMotor Development Contract Signed with H55
12th Jan 20246:31 pmRNSReplacement: Big Bus Repower Contract
10th Jan 20247:00 amRNSBig Bus Repower Contract Doubled to 20 Buses
29th Nov 20235:51 pmRNSResult of AGM
15th Nov 20234:01 pmRNSExercise of Options
3rd Nov 20237:05 amRNSNotice of AGM
9th Oct 20237:00 amRNSOff-Highway Vehicle Project & £3.24m APC Funding
2nd Oct 20237:00 amRNSResults for the year ended 31 May 2023
29th Sep 20237:00 amRNS£1.75m Electric Bus Repower Contract
14th Sep 202312:00 pmRNSHolding(s) in Company
3rd Aug 20237:00 amRNS£1.475m Electric Bus Repower Contract
31st Jul 20237:00 amRNSSuccessful First eVTOL Flight - Vertical Aerospace
14th Jul 20237:00 amRNSTrading Update for the year ended 31 May 2023
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.